Investigations of botanicals on food intake, satiety, weight loss, and oxidative

植物药对食物摄入、饱腹感、减肥和氧化作用的研究

基本信息

  • 批准号:
    7739760
  • 负责人:
  • 金额:
    $ 11.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-01 至 2014-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): My training to date has provided me with a solid understanding of the behavioral, psychosocial, and environmental factors that contribute to eating behavior and weight management; however, my understanding of physiology and the biological mechanisms regulating eating behavior and body weight remains to be improved. Therefore, I seek to increase my knowledge of the physiological aspects of age- related metabolic conditions, and the potential role botanical extracts may have in affecting physiology, eating behavior, body weight, and oxidative stress levels. This knowledge, coupled with my previous training, will provide an ideal foundation from which I can build a unique and independent line of research investigating alternative and adjunctive treatments involving botanicals for age-related metabolic conditions (obesity, type 2 diabetes). My immediate career goals are to 1) obtain a R01 grant to further examine the potential effects of different doses of the selected botanical compounds on food intake, body weight, and oxidative stress levels and 2) increase my understanding of the effects that botanicals have on physiological processes related to food intake. My long-term career goal is to become an independent investigator focused on developing safe and effective alternative or adjunctive interventions involving natural compounds for the treatment of obesity and other metabolic conditions. The proposed line of research will explore the role that botanical compounds have in affecting food intake, neuroendocrine signals, satiety, weight loss, and oxidative stress levels. Study 1 will investigate the effects of two promising botanicals (garcinia cambogia derived hydroxycitric acid, and glucomannan) on food intake, satiety, and weight loss using a double-blind, placebo controlled design. Based on the findings from study 1, the botanical with the most significant effects on food intake will be used in a 24-week, placebo controlled calorie restricted weight loss trial. In addition to body weight, this trial will examine the effects of the selected compound on: 1) food intake, 2) self-reported satiety, 3) postprandial neuroendocrine signals (i.e., CCK, GLP-1, insulin, and leptin), and 4) oxidative stress levels (i.e., DNA and RNA oxidation). PUBLIC HEALTH RELEVANCE: Botanicals represent important sources of potential new adjunctive therapies for obese and insulin resistant individuals and may enhance the health benefits of weight loss interventions by reducing systemic oxidative stress levels.
描述(由申请人提供):到目前为止,我的培训使我对影响饮食行为和体重管理的行为、心理社会和环境因素有了坚实的理解;然而,我对调节饮食行为和体重的生理学和生物学机制的理解仍有待提高。因此,我试图增加我对与年龄相关的代谢状况的生理方面的知识,以及植物提取物在影响生理、饮食行为、体重和氧化应激水平方面的潜在作用。这些知识,再加上我之前的培训,将为我提供一个理想的基础,使我能够建立一条独特而独立的研究路线,研究使用植物药物治疗年龄相关新陈代谢疾病(肥胖症、2型糖尿病)的替代和辅助治疗。我目前的职业目标是1)获得R01补助金,以进一步研究不同剂量的选定植物化合物对食物摄入量、体重和氧化应激水平的潜在影响,以及2)加深我对植物物质对与食物摄入相关的生理过程的影响的理解。我的长期职业目标是成为一名独立的调查员,专注于开发安全有效的替代或辅助干预措施,使用天然化合物治疗肥胖症和其他代谢疾病。拟议的研究路线将探索植物化合物在影响食物摄入量、神经内分泌信号、饱腹感、体重减轻和氧化应激水平方面所起的作用。研究1将采用双盲、安慰剂对照设计,调查两种有前景的植物性药物(藤黄提取的羟基柠檬酸和葡甘聚糖)对食物摄入量、饱腹感和减肥的影响。根据研究1的发现,对食物摄入量有最显著影响的植物将用于一项为期24周的安慰剂控制卡路里限制减肥试验。除了体重,这项试验还将检查所选化合物对以下方面的影响:1)食物摄入量,2)自我报告的饱腹感,3)餐后神经内分泌信号(即CCK、GLP-1、胰岛素和瘦素),以及4)氧化应激水平(即DNA和RNA氧化)。 公共卫生相关性:植物药是肥胖和胰岛素抵抗患者潜在新辅助疗法的重要来源,并可能通过降低全身氧化应激水平来增强减肥干预的健康益处。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stephen D Anton其他文献

Stephen D Anton的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stephen D Anton', 18)}}的其他基金

Functional Decline in Low Functioning Older Adults; Role of iron dysregulation
功能低下的老年人的功能衰退;
  • 批准号:
    10689810
  • 财政年份:
    2022
  • 资助金额:
    $ 11.39万
  • 项目类别:
Tailoring Recruitment Communication using Virtual Human Technology to Increase Participation of Older Minority Adults in Clinical Trials
使用虚拟人技术定制招聘沟通,以增加老年少数族裔成年人对临床试验的参与
  • 批准号:
    10332981
  • 财政年份:
    2021
  • 资助金额:
    $ 11.39万
  • 项目类别:
Tailoring Recruitment Communication using Virtual Human Technology to Increase Participation of Older Minority Adults in Clinical Trials
使用虚拟人技术定制招聘沟通,以增加老年少数族裔成年人对临床试验的参与
  • 批准号:
    10674054
  • 财政年份:
    2021
  • 资助金额:
    $ 11.39万
  • 项目类别:
The University of Florida Jacksonville Aging Studies Center (JAX-ASCENT)
佛罗里达大学杰克逊维尔老龄化研究中心 (JAX-ASCENT)
  • 批准号:
    10212912
  • 财政年份:
    2017
  • 资助金额:
    $ 11.39万
  • 项目类别:
The University of Florida Jacksonville Aging Studies Center (JAX-ASCENT)
佛罗里达大学杰克逊维尔老龄化研究中心 (JAX-ASCENT)
  • 批准号:
    9981558
  • 财政年份:
    2017
  • 资助金额:
    $ 11.39万
  • 项目类别:
The University of Florida Jacksonville Aging Studies Center (JAX-ASCENT)
佛罗里达大学杰克逊维尔老龄化研究中心 (JAX-ASCENT)
  • 批准号:
    10474718
  • 财政年份:
    2017
  • 资助金额:
    $ 11.39万
  • 项目类别:
The University of Florida Jacksonville Aging Studies Center (JAX-ASCENT)
佛罗里达大学杰克逊维尔老龄化研究中心 (JAX-ASCENT)
  • 批准号:
    9371690
  • 财政年份:
    2017
  • 资助金额:
    $ 11.39万
  • 项目类别:
JAX-Mobility Aging Pain Disparities (MAPD): A Feasibility Study.
JAX-移动性老化疼痛差异 (MAPD)​​:可行性研究。
  • 批准号:
    10267888
  • 财政年份:
    2017
  • 资助金额:
    $ 11.39万
  • 项目类别:
REVIVE - Resveratrol to enhance vitality and vigor in elders
REVIVE - 白藜芦醇增强老年人的活力和活力
  • 批准号:
    8849377
  • 财政年份:
    2013
  • 资助金额:
    $ 11.39万
  • 项目类别:
REVIVE - Resveratrol to enhance vitality and vigor in elders
REVIVE - 白藜芦醇增强老年人的活力和活力
  • 批准号:
    8578756
  • 财政年份:
    2013
  • 资助金额:
    $ 11.39万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.39万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.39万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 11.39万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.39万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.39万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.39万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.39万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 11.39万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 11.39万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 11.39万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了